<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04581174</url>
  </required_header>
  <id_info>
    <org_study_id>FNO-ENT-turbinates_hypertrophy</org_study_id>
    <nct_id>NCT04581174</nct_id>
  </id_info>
  <brief_title>Effect of Extraesophageal Reflux on Inferior Nasal Turbinates Hypertrophy</brief_title>
  <official_title>Effect of Extraesophageal Reflux on Inferior Nasal Turbinates Hypertrophy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Ostrava</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University Hospital Bratislava</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Fortmedica Prague</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital Ostrava</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study examines the severity of extraesophageal reflux using oropharyngeal pH monitoring&#xD;
      in patients with varying degrees of lower turbinates hypertrophy.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Hypertrophy of the lower turbinates causes obstruction of the nasal breathing with several&#xD;
      health risks and a significant reduction in quality of life. Mouth breathing is&#xD;
      non-physiological. When breathing through the mouth, the air is not purified, warmed, or&#xD;
      humidified. This results in more frequent respiratory infections, drying of the airways,&#xD;
      burning in the throat and causes snoring and sleep apnoea overnight. Also, nasal obstruction&#xD;
      leads to a significant reduction in quality of life. Conservative treatment with topically&#xD;
      applied corticosteroids is often without effect and surgical reduction of the lower&#xD;
      turbinates under local or general anesthesia is necessary. The operation is another&#xD;
      discomfort for the patient and is not without risks.&#xD;
&#xD;
      The pathogenesis of lower turbinates hypertrophy is multifactorial. Currently,&#xD;
      extraesophageal reflux (EER) is considered to be a possible factor as well. The role of EER&#xD;
      in chronic rhinosinusitis, especially in difficult-to-treat conditions, has been investigated&#xD;
      in the past, and EER would likely be a possible co-factor. The relationship between&#xD;
      hypertrophic lower turbinates and EER has not been studied yet.&#xD;
&#xD;
      The primary outcome/goal of the study:&#xD;
&#xD;
      To examine the severity of extraesophageal reflux using oropharyngeal pH monitoring in&#xD;
      patients with varying degrees of lower turbinates hypertrophy.&#xD;
&#xD;
      Other goals:&#xD;
&#xD;
        -  To compare extraesophageal reflux severity in patients with posterior inferior turbinate&#xD;
           hypertrophy.&#xD;
&#xD;
        -  To evaluate the difference between anterior and posterior hypertrophy of the inferior&#xD;
           turbinates in patients with proven extraesophageal reflux.&#xD;
&#xD;
        -  To evaluate the lateral difference of lower turbinates hypertrophy in patients with&#xD;
           proven EER and in patients without proven EER.&#xD;
&#xD;
      Study protocol:&#xD;
&#xD;
        -  anamnestic questionnaire (age, sex, weight, height, smoking, alcohol, reflux disease,&#xD;
           treatment with topical corticosteroids, treatment of reflux disease)&#xD;
&#xD;
        -  Reflux Symptom Index (RSI) questionnaire&#xD;
&#xD;
        -  Sino-Nasal Outcome Test (SNOT 22) questionnaire&#xD;
&#xD;
        -  rhinomanometry (optional - if available)&#xD;
&#xD;
        -  acoustic rhinometry (optional - if available)&#xD;
&#xD;
        -  olfactory questionnaire (optional - if available)&#xD;
&#xD;
        -  endoscopy of the nasal cavity with evaluation:&#xD;
&#xD;
        -  of the degree of hypertrophy of the lower turbinates according to Camacho, 2014 (for&#xD;
           both turbinates separately and separately anterior and posterior half of the turbinates)&#xD;
           (attachment 1)&#xD;
&#xD;
        -  of bulky posterior inferior turbinate hypertrophy&#xD;
&#xD;
        -  of reddening of the posterior ends of the lower turbinates&#xD;
&#xD;
        -  of reddening of nasopharynx&#xD;
&#xD;
        -  24-hour monitoring of oropharyngeal pH by Restech, RYAN score upright and supine and pH&#xD;
           values &lt;5.5 will be evaluated&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 15, 2020</start_date>
  <completion_date type="Anticipated">October 2021</completion_date>
  <primary_completion_date type="Anticipated">September 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>The study subjects will be enrolled to a total of four study arms, depending on the degree of inferior turbinates hypertrophy (according to Camacho)</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
    <masking_description>No masking is being used in this study</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Severity of extraesophageal reflux using oropharyngeal pH monitoring</measure>
    <time_frame>24 hours</time_frame>
    <description>The primary outcome measure of the study is to examine the severity of extraesophageal reflux using oropharyngeal pH monitoring in patients with varying degrees of lower turbinates hypertrophy, assessed on the RYAN score.</description>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">160</enrollment>
  <condition>Inferior Nasal Turbinate Hypertrophy</condition>
  <condition>Extraesophageal Reflux</condition>
  <arm_group>
    <arm_group_label>1st degree of hypertrophy according to Camacho</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients with 1st degree of hypertrophy according to Camacho will undergo 24-hour monitoring of oropharyngeal pH by Restech, RYAN scores upright and supine, and pH values &lt;5.5 will be evaluated.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2nd degree of hypertrophy according to Camacho</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients with 2nd degree of hypertrophy according to Camacho will undergo 24-hour monitoring of oropharyngeal pH by Restech, RYAN scores upright and supine, and pH values &lt;5.5 will be evaluated.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3rd degree of hypertrophy according to Camacho</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients with 3rd degree of hypertrophy according to Camacho will undergo 24-hour monitoring of oropharyngeal pH by Restech, RYAN scores upright and supine, and pH values &lt;5.5 will be evaluated.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>4th degree of hypertrophy according to Camacho</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients with 4th degree of hypertrophy according to Camacho will undergo 24-hour monitoring of oropharyngeal pH by Restech, RYAN scores upright and supine, and pH values &lt;5.5 will be evaluated.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>24-hour monitoring of oropharyngeal pH by Restech, RYAN scores upright and supine, and pH values &lt;5.5 will be evaluated</intervention_name>
    <description>Patients with the 1st degree of hypertrophy according to Camacho, 2nd degree of hypertrophy according to Camacho, 3rd degree of hypertrophy according to Camacho, 4th degree of hypertrophy according to Camacho will undergo 24-hour monitoring of oropharyngeal pH by Restech, RYAN scores upright and supine, and pH values &lt;5.5 will be evaluated.</description>
    <arm_group_label>1st degree of hypertrophy according to Camacho</arm_group_label>
    <arm_group_label>2nd degree of hypertrophy according to Camacho</arm_group_label>
    <arm_group_label>3rd degree of hypertrophy according to Camacho</arm_group_label>
    <arm_group_label>4th degree of hypertrophy according to Camacho</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  age 18-80 years&#xD;
&#xD;
          -  patients indicated for oropharyngeal pH-metry (Restech) with suspected extraesophageal&#xD;
             reflux&#xD;
&#xD;
          -  patients with 2nd - 4th degree hypertrophy of the lower turbinates (according to&#xD;
             Camacho Classification)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  patients with chronic rhinosinusitis with polyps&#xD;
&#xD;
          -  patients who have had an acute upper respiratory tract infection in the last 8 weeks&#xD;
&#xD;
          -  patients after previous surgery in the nasal cavity and nasopharynx&#xD;
&#xD;
          -  patients after radiotherapy in the head and neck area&#xD;
&#xD;
          -  non tolerance of pH catheter&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Karol Zeleník, Ass.Prof.,MD,PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Ostrava</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Petr Vávra, Ass.Prof.,MD,PhD</last_name>
    <phone>0042059737</phone>
    <phone_ext>2544</phone_ext>
    <email>veda@fno.cz</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jiří Hynčica</last_name>
    <phone>0042059737</phone>
    <phone_ext>2587</phone_ext>
    <email>jiri.hyncica@fno.cz</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Hospital Ostrava</name>
      <address>
        <city>Ostrava</city>
        <state>Moravian-Silesian Region</state>
        <zip>70852</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Petr Vávra, Ass.Prof.,MD,PhD</last_name>
      <phone>0042059737</phone>
      <phone_ext>2544</phone_ext>
      <email>veda@fno.cz</email>
    </contact>
    <contact_backup>
      <last_name>Jiří Hynčica</last_name>
      <phone>0042059737</phone>
      <phone_ext>2587</phone_ext>
      <email>jiri.hyncica@fno.cz</email>
    </contact_backup>
    <investigator>
      <last_name>Karol Zeleník, Ass.Prof.,MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jakub Lubojacký, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Martin Formánek, MD,PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Viktória Hránková, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Petr Matoušek, MD,PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fortmedica Prague</name>
      <address>
        <city>Praha</city>
        <zip>14300</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Renáta Taimrová, MD</last_name>
      <phone>00420725828068</phone>
    </contact>
    <investigator>
      <last_name>Renáta Taimrová, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Comenius University, University Hospital Bratislava</name>
      <address>
        <city>Bratislava</city>
        <zip>85107</zip>
        <country>Slovakia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Miroslav Tedla, Ass.Prof.,MD,PhD,MPH</last_name>
      <phone>00421917999701</phone>
      <email>kontakt@mirotedla.sk</email>
    </contact>
    <investigator>
      <last_name>Miroslav Tedla, Ass.Prof.,MD,PhD,MPH</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Zuzana Javorská, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Kristína Lukáčová, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Czechia</country>
    <country>Slovakia</country>
  </location_countries>
  <reference>
    <citation>Camacho M, Zaghi S, Certal V, Abdullatif J, Means C, Acevedo J, Liu S, Brietzke SE, Kushida CA, Capasso R. Inferior turbinate classification system, grades 1 to 4: development and validation study. Laryngoscope. 2015 Feb;125(2):296-302. doi: 10.1002/lary.24923. Epub 2014 Sep 12.</citation>
    <PMID>25215619</PMID>
  </reference>
  <reference>
    <citation>Farmer SE, Eccles R. Chronic inferior turbinate enlargement and the implications for surgical intervention. Rhinology. 2006 Dec;44(4):234-8. Review.</citation>
    <PMID>17216738</PMID>
  </reference>
  <reference>
    <citation>Camacho M, Zaghi S, Certal V, Abdullatif J, Modi R, Sridhara S, Tolisano AM, Chang ET, Cable BB, Capasso R. Predictors of Nasal Obstruction: Quantification and Assessment Using Multiple Grading Scales. Plast Surg Int. 2016;2016:6945297. doi: 10.1155/2016/6945297. Epub 2016 May 16.</citation>
    <PMID>27293885</PMID>
  </reference>
  <reference>
    <citation>Ayazi S, Lipham JC, Hagen JA, Tang AL, Zehetner J, Leers JM, Oezcelik A, Abate E, Banki F, DeMeester SR, DeMeester TR. A new technique for measurement of pharyngeal pH: normal values and discriminating pH threshold. J Gastrointest Surg. 2009 Aug;13(8):1422-9. doi: 10.1007/s11605-009-0915-6. Epub 2009 May 7.</citation>
    <PMID>19421822</PMID>
  </reference>
  <reference>
    <citation>Chheda NN, Seybt MW, Schade RR, Postma GN. Normal values for pharyngeal pH monitoring. Ann Otol Rhinol Laryngol. 2009 Mar;118(3):166-71.</citation>
    <PMID>19374146</PMID>
  </reference>
  <reference>
    <citation>Wiener GJ, Tsukashima R, Kelly C, Wolf E, Schmeltzer M, Bankert C, Fisk L, Vaezi M. Oropharyngeal pH monitoring for the detection of liquid and aerosolized supraesophageal gastric reflux. J Voice. 2009 Jul;23(4):498-504. doi: 10.1016/j.jvoice.2007.12.005. Epub 2008 May 12.</citation>
    <PMID>18468849</PMID>
  </reference>
  <reference>
    <citation>Zeleník K, Matoušek P, Formánek M, Urban O, Komínek P. Patients with chronic rhinosinusitis and simultaneous bronchial asthma suffer from significant extraesophageal reflux. Int Forum Allergy Rhinol. 2015 Oct;5(10):944-9. doi: 10.1002/alr.21560. Epub 2015 Jun 5.</citation>
    <PMID>26046448</PMID>
  </reference>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>October 2, 2020</study_first_submitted>
  <study_first_submitted_qc>October 2, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 9, 2020</study_first_posted>
  <last_update_submitted>February 22, 2021</last_update_submitted>
  <last_update_submitted_qc>February 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 23, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Inferior nasal turbinate hypertrophy</keyword>
  <keyword>Extraesophageal reflux</keyword>
  <keyword>Oropharyngeal pH monitoring</keyword>
  <keyword>Restech system</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gastroesophageal Reflux</mesh_term>
    <mesh_term>Hypertrophy</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Individual participant data may be made available to other researchers upon request.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

